Atherosclerosis
Volume 148, Issue 1 , Pages 131-139 , January 2000

Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?

  • F.Javier Nieto

      Affiliations

    • Department of Epidemiology, The Johns Hopkins University, School of Hygiene and Public Health, 615 North Wolfe Street, room W6009, Baltimore, MD 21205, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-410-9554380; fax: +1-410-9558086
    • ,
  • Carlos Iribarren

      Affiliations

    • Kaiser Permanente Division of Research, Oakland, CA 94611, USA
    • ,
  • Myron D. Gross

      Affiliations

    • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN, 55454 USA
    • ,
  • George W. Comstock

      Affiliations

    • Department of Epidemiology, The Johns Hopkins University, School of Hygiene and Public Health, 615 North Wolfe Street, room W6009, Baltimore, MD 21205, USA
    • ,
  • Richard G. Cutler

      Affiliations

    • Genox Corporation, Baltimore, MD 21230, USA

Received 2 November 1998 ,Revised 21 May 1999 ,Accepted 2 June 1999.

References 

  1. Manson JA, Gaziano JM, Jonas MA, Hennekens CH. Antioxidants and cardiovascular disease: a review. J. Am. Coll. Nutr. 1993;12:426–432
  2. Hoffman RM, Garewal HS. Antioxidants and the prevention of coronary heart disease. Arch. Intern. Med. 1995;155:241–246
  3. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerosis heart disease. N. Engl. J. Med. 1997;337:408–416
  4. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction?. Circulation. 1994;90:1154–1161
  5. Stephens NG, Parsons A, Schofield PM, et al.  Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidants Study (CHAOS). Lancet. 1996;347:781–786
  6. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029–35.
  7. Hennekens CH, Buring JE, Manson JE, et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasm and cardiovascular disease. N. Engl. J. Med. 1996;334:1145–1149
  8. Rapola JM, Virtamo J, Haukka JK, et al.  Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double blind, controlled trial. J. Am. Med. Assoc. 1996;275:693–698
  9. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA. 1989;86:6377–6381
  10. Ramirez J, Flowers NC. Leukocyte ascorbic acid and its relationship to coronary heart disease in man. Am. J. Clin. Nutr. 1980;33:2079–2087
  11. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992;3:194–202
  12. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA. 1981;78:6858–6862
  13. Sevanian A, Davies KJ, Hochstein P. Conservation of vitamin C by uric acid in blood. J. Free. Rad. Biol. Med. 1985;1:117–124
  14. Emmerson BT. Atherosclerosis and urate metabolism. Aust. N. Z. J. Med. 1979;9:451–454
  15. The Hypertension Detection and Follow-up Program Cooperative Research Group. Mortality findings for stepped-care and referred-care participants in the Hypertension Detection and Follow-up Program, stratified by other risk factors. Prev Med 1985;14:312–35.
  16. Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J. Hyperuricemia and risk of cardiovascular disease and overall death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta. Med. Scand. 1988;224:549–555
  17. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study. Ann. Epidemiol. 1996;6:331–340
  18. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am. J. Epidemiol. 1984;119:653–656
  19. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am. J. Epidemiol. 1985;121:11–18
  20. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am. J. Epidemiol. 1995;141:637–644
  21. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am. Heart. J. 1985;114:413–419
  22. Iribarren C, Sharp DS, Curb JD, Yano K. High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers?. J. Clin. Epidemiol. 1996;49:673–678
  23. ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives, Am J Epidemiol 1989;129:687–702.
  24. Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free. Rad. Biol. Med. 1993;14:303–311
  25. Cao G, Verdon CP, Wu AHB, Wang H, Prior RL. Automated assay of oxygen-radical absorbance capacity with the COBAS FARA II. Clin. Chem. 1995;41:1738–1744
  26. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine. Results from the ‘Clue’ Study and the ARIC Study. J. Am. Med. Assoc. 1993;269:488–493
  27. Nieto FJ, Adam E, Sorlie P, et al.  A prospective study of cytomegalovirus and other herpes viruses as predictors of subclinical atherosclerosis. Circulation. 1996;94:922–927
  28. Comstock GW, Menkes MS, Schober SE, Vuilleumier J-P, Helsing KJ. Serum levels of retinol, beta-carotene, and alpha-tocopherol in older adults. Am. J. Epidemiol. 1988;127:114–123
  29. Comstock GW, Bush TL, Helzlsouer KJ, Hoffman SC. The Washington County training center: an exemplar of public health research in the field. Am. J. Epidemiol. 1991;134:1023–1029
  30. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1406
  31. Iribarren C, Folsom AR, Jacobs DR, Gross M, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibody against modified LDL with asymptomatic carotid atherosclerosis: the ARIC study. Atheroscler. Thromb. Vasc. Biol. 1997;17:1171–1177
  32. Bieri JG, Brown ED, Smith JC. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J. Liq. Chromatogr. 1985;8:473–484
  33. Craft NE, Brown ED, Smith JC. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin. Chem. 1988;34:44–48
  34. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin. Chem. 1983;29:1075–1080
  35. Nagele U, Hagele EO, Sauer G, et al.  Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J. Clin. Chem. Biochem. 1984;22:1075–1080
  36. Nieto FJ, Diez-Roux A, Sxklo M, et al. Short and long term predictors of atherosclerosis by traditional risk factors. J Clin Epidemiol 1999 52:559–67.
  37. Mustard JF, Murphy EA, Ogryzlo MA, Smythe HA. et al. Blood coagulation and platelet economy in subjects with primary goat. Can Med Assoc J 1963;89:1207–11.
  38. Newland H. Hyperuricemia in coronary, cerebral, and peripheral arterial disease: an explanation. Med. Hypotheses. 1975;1:152–155
  39. Ginsberg MH, Kozin F, O'Malley M, McCarty DJ. Release of platelet constituents by monosodium urate crystals. J. Clin. Invest. 1977;60:999–1007
  40. Ferris TF, Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am. J. Med. 1968;44:359–365
  41. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular disease. Ann. Intern. Med. 1980;93:817–821
  42. Frohlich ED. Uric acid. A risk factor for coronary heart disease [Editorial]. J. Am. Med. Assoc. 1993;270:378–379
  43. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am. J. Epidemiol. 1995;142:288–294
  44. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. J. Am. Med. Assoc. 1993;270:354–359
  45. Sevanian A, Davies KJ, Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr. 1991;54:1129–1134
  46. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem. J. 1986;235:747–754
  47. Navab M, Berliner JA, Watson AD, et al.  The yin and yang of oxidation in the development of the fatty streak: a review based on the George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 1996;16:831–842
  48. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA. 1987;84:5918–5922
  49. Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease among men in the Multiple Risk Factor Intervention Trial (MRFIT). Am. J. Epidemiol. 1998;147(2):180–186
  50. Comstock GW, Alberg AJ, Helzlsouer KJ. Reported effects of long-term freezer storage on concentrations of retinol, β-carotene and α-tocopherol in serum or plasma summarized. Clin. Chem. 1993;39:1075–1078
  51. Comstock GW, Norkus EP, Hoffman SC, Xu MW, Helzlsouer KJ, et al.  Stability of ascorbic acid, carotenoids, retinol, and tocopherols in plasma stored at −70°C for 4 years. Can. Epidemiol. Biomarkers. Prev. 1995;4:505–507

PII: S0021-9150(99)00214-2

Atherosclerosis
Volume 148, Issue 1 , Pages 131-139 , January 2000

Article Tools

* Image Usage & Resolution